Peptide record

TPDB45780

Antiviral standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45780
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 16-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
GWKRIKQRIKDKLRNL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C92H162N32O21
ACEHMFPSTYV
K
2052.50
12.16
7
1
5
+6
4.06
-1.519
97.50
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5500
2.68
2
Residue Composition
number
0
A
3
R
1
N
1
D
0
C
0
E
1
Q
1
G
0
H
2
I
2
L
4
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 1 D: 1 C: 0 E: 0 Q: 1 G: 1 H: 0 I: 2 L: 2 K: 4 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
16 reviewed residue count
C92H162N32O21 sequence-only estimate (linear, free termini)
2052.50 sequence-only estimate (linear, free termini)
12.16 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
4.06 sequence-only estimate (linear, free termini)
-1.519 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

Antiviral

Source & Reference

DRAVP 2.0

Other

inhibited herpes simplex virus 1 (HSV-1) infection in epithelial and neuronal cells.